已收盘 02-06 16:00:00 美东时间
+0.150
+0.33%
今日重点评级关注:Benchmark:维持Charter Communications"买入"评级,目标价从425美元升至455美元;BTIG:维持LifeStance Health Gr"买入"评级,目标价从10美元升至11美元
02-03 09:06
Origin Bancorp (NYSE:OBK) has been analyzed by 4 analysts in the last three mon...
02-03 06:01
今日重点评级关注:HC Wainwright & Co.:维持Praxis Precision Medicine"买入"评级,目标价从340美元升至1245美元;HC Wainwright & Co.:维持Perspective Therapeutics"买入"评级,目标价从10美元升至12美元
02-02 14:15
DA Davidson analyst Gary Tenner maintains Origin Bancorp (NYSE:OBK) with a Buy and raises the price target from $42 to $49.
01-31 03:33
Origin Bancorp (NYSE:OBK) reported quarterly earnings of $0.95 per share which beat the analyst consensus estimate of $0.86 by 10.08 percent. This is a 106.52 percent increase over earnings of $0.46 per share from the
01-29 05:36
Companies Reporting Before The Bell • VF (NYSE:VFC) is estimated to report quar...
01-28 19:11
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying Banco Santander, S.A. saying it is "terrific."
01-16 21:24
今日重点评级关注:HC Wainwright & Co.:维持BiomX"买入"评级,目标价从15美元升至26美元;Clear Street:维持Diversified Energy"买入"评级,目标价从23美元升至25美元
2025-11-26 10:07
DA Davidson analyst Gary Tenner assumes Origin Bancorp (NYSE:OBK) with a Buy rating and lowers Price Target of $42.
2025-11-26 02:38
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
2025-10-28 10:08